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Ethnopharmacological relevance: In Brazilian traditional medicine, Arctium lappa (Asteraceae), has been
reported to relieve gastrointestinal symptoms.
Aim of the study: In the present study, we investigated the effects of the lactone sesquiterpene
onopordopicrin enriched fraction (ONP fraction) from Arctium lappa in an experimental colitis model
induced by 2,4,6 trinitrobenzene sulfonic acid and performed experiments to elucidate the underlying
action mechanisms involved in that effect.
Materials and methods: ONP fraction (25 and 50 mg/kg/day) was orally administered 48, 24 and 1 h
prior to the induction of colitis and 24 h after. The inﬂammatory response was assessed by gross
appearance, myeloperoxidase (MPO) activity, tumor necrosis factor alpha (TNF-a) levels and a
histological study of the lesions. We determined cyclooxygenase (COX)-1 and -2 protein expressions
by western blotting and immunohistochemistry assays.
Results: TNBS group was characterized by increased colonic wall thickness, edema, diffuse inﬂamma-
tory cell inﬁltration, increased MPO activity and TNF-a levels. On the contrary, ONP fraction (25 and
50 mg/kg) treatment signiﬁcantly reduced the macroscopic inﬂammation scores (po0.05 and po0.01,
respectively) and morphological alterations associated with an increase in the mucus secretion.
Similarly, the degree of neutrophil inﬁltration and the cytokine levels were signiﬁcantly ameliorated.
Moreover, COX-2 expression was up regulated in TNBS-treated rats. In contrast, ONP fraction (50 mg/
kg) administration reduced COX-2 overexpression.
Conclusions: We have shown that the ONP fraction obtained from Arctium lappa exert marked
protective effects in acute experimental colitis, conﬁrming and justifying, at least in part, the popular
use of this plant to treat gastrointestinal diseases.
& 2013 Elsevier Ireland Ltd. Open access under the Elsevier OA license. 1. Introduction
The inﬂammatory bowel diseases (IBD) comprise two main
types of chronic intestinal disorders: Crohn’s disease (CD) and
ulcerative colitis (UC) (Singh et al., 2012). The etiology of IBD is
still not entirely elucidated, but the characteristic disproportion-
ate inﬂammatory response in the gut may be developed through
various mechanisms at the cellular and intracellular levels (Magroiences, Federal University of
434415348;
erson Luiz-Ferreira).
r the Elsevier OA license. and Portela, 2010). As well as some other autoimmune diseases,
the overproduction of tumor necrosis factor alpha (TNF-a) is
prevalent in the inﬂamed tissues and plays a central role in
inﬂammation (Lee and Fedorak, 2010; Hai et al., 2011). One major
consequence of this signaling in the gut is the increased produc-
tion of prostaglandin E2 (PGE2) via cyclooxygenase -2 (COX-2), the
inducible isoform of the enzyme, which has been recognized to be
a key factor in diverse inﬂammatory conditions such as IBD (Wu,
2005).
Arctium lappa L. (Asteraceae), popularly known as ‘‘bardana’’, is
used in folk medicine as diuretic, depurative, digestive stimulant
and anti-inﬂammatory (de Almeida A.B. et al., 2012; de Almeida
A.B.A. et al., 2012). Recently, various studies have evaluated the
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genic (de Almeida A.B. et al., 2012; de Almeida A.B.A. et al., 2012),
antioxidant (Predes et al., 2011), anti-allergic and anti-
inﬂammatory activities (Soh et al., 2011). In addition, arctigenin
a bioactive lignin isolated from Arctium lappa, has many biological
activities such as inhibition of inducible nitric oxide synthase and
interleukin-6 (Zhao et al., 2009), interleukin-2 and interferon
gamma (Tsai et al., 2011) and TNF-a production in macrophages
(Cho et al., 2004). In this sense, Huang et al. (2010) evaluated the
anti-inﬂammatory activity of Arctium lappa L in a dextran sodium
sulfate (DSS) model, which resembles UC. However, there is no
report studying Arctium lappa effects in 2,4,6 trinitrobenzene
sulfonic acid (TNBS)-induced colitis model, which mimics CD (te
Velde et al., 2006). Therefore, the present study was designed to
examine the intestinal anti-inﬂammatory effects of the lactone
sesquiterpene onopordopicrin (ONP)-enriched fraction (hereafter
ONP fraction) from Arctium lappa in an acute TNBS-induced
experimental colitis model which shares some histological and
biochemical features to the human disease (Morris et al., 1989).
Furthermore, we studied macroscopic and histological para-
meters and analyzed some inﬂammatory colonic mediators such
as TNF-a production, COX-2 expression, and MPO activity.2. Materials and methods
2.1. Animals and reagents
Male Wistar rats (170–190 g) obtained from the Laboratory
Animal Service of the University of Seville (Seville, Spain) were
housed individually in Makrolon cages (45 cm long35 cm
high20 cm wide), maintained in air-conditioned animal quar-
ters with a 12 h light/dark cycle, and fed standard rodent chow
(Panlab A04, Panlab, Seville, Spain) and water ad libitum through-
out the experiment. All experiments were in accordance with the
recommendations of the European Union regarding animal
experimentation (Directive of the European Council 86/609/EC),
and followed also a protocol approved by the local animal Ethics
Committee and the local Government. ONP fraction was isolated
and characterized by GC–MS from Arctium lappa according de
Almeida A.B. et al. (2012); de Almeida A.B.A. et al. (2012). TNBS
and others chemicals were obtained from Sigma Chemical
(Madrid, Spain), unless otherwise stated.
2.2. Plant material
Leaves of Arctium lappa were collected in Mogi Mirim, SP,
Brazil in July 2000 by Dr. Ana Beatriz Albino de Almeida. A
voucher herbarium specimen was deposited in the Herbarium
of the State University of Campinas (voucher number 131.966).
2.3. Induction of colitis
Colitis was induced according to the procedure described by
Morris et al., (1989). Brieﬂy, rats were slightly anaesthetized with
ether following a 24 h fast, and then TNBS (Sigma-Aldrich
Company Ltd., Spain) dissolved in 50% ethanol was instilled into
the colon of the animals (10 mg in a volume of 0.25 mL) using a
medical-grade polyurethane catheter for enteral feeding (external
diameter 2 mm) inserted 8 cm into the anus. Following the
instillation of the hapten, the animals were kept in a head-
down position for a 1 min to prevent leakage. Different control
groups were created for comparison with TNBS/ethanol instilla-
tion: rats in the sham group received an enema of physiological
saline instead of the TNBS solution, and ethanol group received
0.25 mL of 50% ethanol. ONP fraction (25 and 50 mg/kg p.o.) wassuspended in 12% Tweens 80 solution (10 mL/kg animal) and
administered by gavage 48, 24 and 1 h prior to the induction of
colitis and 24 h after. The doses of 25 and 50 mg/Kg of ONP
fraction were chosen based in dose-response study previously
performed in our laboratory (de Almeida A.B. et al., 2012). Control
groups received vehicle in a comparable volume. The animals
were sacriﬁced, using an overdose of anesthetic, 48 h after
induction of colitis. The rats were checked daily for behavior,
body weight, and stool consistency.
2.4. Assessment of colonic damage
The severity of colitis was evaluated by an independent
observer who was blinded to the treatment. For each animal,
the distal 10 cm portion of the colon was removed and cut
longitudinally, slightly cleaned in physiological saline to remove
fecal residues and weighed. Macroscopic inﬂammation scores
were assigned based on clinical features of the colon (Sa´nchez-
Hidalgo et al., 2005). The presence of adhesions (score 0–2), and/
or stool consistency (score 0–1) were evaluated according to the
criteria of Bobin-Dubigeon et al. (2001). Pieces of inﬂamed colon
were collected and frozen in liquid nitrogen to measure biochem-
ical parameters.
2.5. Histological analysis
For examination with the light microscope we used tissue
samples from the distal colon of each animal ﬁxed in 4% buffered
paraformaldehyde, dehydrated in grade ethanol, and embedded
in parafﬁn. Thereafter, sections of tissue were cut at 5 mm on a
rotary microtome (Leica Ultracut), mounted on clean glass slides
and dried overnight at 37 1C. Sections were cleared, hydrated, and
stained with haematoxylin and eosin, Giemsa, and Alcian blue for
histological evaluation of colonic damage, cell inﬁltration and
mucus content respectively, according to standard protocols, and
the slides were coded to prevent observer bias during evaluation.
All tissue sections were examined in an Olympus BH-2 micro-
scope for characterization of histopathological changes.
Photographs taken from colon samples were digitized using
Kodak D290 Zoom camera Eastman Kodak Co., USA and Motics
Images 2000 release 1.1 (MicroOptic Industrial Group Co., Ltd.; B1
Series System Microscopes). Analysis of the ﬁgures was carried
out by Adobes Photoshops Version 5.0 (Adobe Systems) image
analysis program.
2.6. Immunohistochemical study
Immunohistochemical analysis was performed using the tech-
nique described by Sa´nchez-Hidalgo et al. (2005). Colonic tissues
were ﬁxed in 4% buffered paraformaldehyde, dehydrated through
graded concentrations of ethanol, embedded in parafﬁn, and
sectioned. Sections (5 mm thick) were mounted on slides, cleared,
and hydrated. All of them were treated with a buffered blocking
solution (3% bovine serum albumin) for 15 min. Then, sections
were co-incubated with primary antibodies for COX-1 and COX-2
(goat polyclonal, M-19 and M-20 of Santa Cruz Biotechnologies,
CA, USA) at a dilution of 1:400 at room temperature for 1 and
24 h, respectively. Sections were washed with phosphate-
buffered saline (PBS) and co-incubated with secondary antibody
(anti-sheep IgG, peroxidasic conjugated, Sigma, Spain) (1:500 in
PBS, v/v), at room temperature for 1 h. Thereafter, sections were
washed as before and with Tris–HCl 0.05 M, pH 7.66, and then co-
incubated with a 3,30-diaminobenzidine solution in darkness
at room temperature for 10 min. Sections were washed with
Tris–HCl, stained with haematoxylin according to standard pro-
tocols and observed under an Olympus BH-2 microscope.
Table 1
Quantiﬁed parameters after administration of ONP fraction (25 and 50 mg/kg p.o.)
in rats with acute colitis induced by TNBS intracolonic instillation (10 mg/animal).
Colonic parameters were quantiﬁed in the Tween group (n¼14), which received
saline instillation. TNBS group (n¼14) received TNBS intracolonically in a vehicle
of 50% (v/v) ethanol; ethanol group (n¼14) received 50% (v/v) ethanol intracolonic
injection. Data are expressed as means7SEM. npo0.05, nnpo0.01, and
nnnpo0.001, signiﬁcantly different from Tween; þpo0.05, þþpo0.01 and
þþþpo0.001, signiﬁcantly different from TNBS.
Group
Body weight
changes (g)
Adhesions
(score 0–2)
Diarrhea
(score 0–1)
Colon weight/
colon length
(mg/cm)
Tween 1475.38 070 070 9877
EtOH 30717.55þþþ 170.27 070þ 130710þ
TNBS 2178.19nn 6.3670.93nn 1.4270.78þþ 280790nnn
TNBSþONP
25
1374.78 2.6770.42þþ 0.8370.75 260753nn
TNBSþONP
50
1772.64n 3.6770.71þ 0.8570.69 240740nn
Tween Ethanol TNBS ONP 25 ONP 50
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Fig. 1. Effects of acute administration of ONP fraction on the colon damage score.
Colonic macroscopic damage resulting from TNBS (10 mg/animal) instilled into rat
colon was scored in Section 2. Scores were quantiﬁed in the absence of treatment,
but with daily administration of the vehicle 12% Tween 80s solution (Tween,
Ethanol and TNBS groups), and in the presence of ONP fraction (25 and 50 mg/kg/
day p.o.). The data are expressed as the means7SEM. *po0.05, **po0.01,
***po0.001 vs. TNBS group.
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MPO activity was assessed as a marker of neutrophil inﬁltration
according to the methods of Grisham et al. (1994). In all animals one
sample from the distal colon was obtained. Samples were excised
from each animal and rapidly rinsed with ice-cold saline, blotted
dry, and frozen at 70 1C. The tissue was thawed, weighed and
homogenized in 10 vol. 50 mM PBS, pH 7.4. The homogenate was
centrifuged at 20,000g, 20 min, 4 1C. The pellet was again homo-
genized in 10 vol. 50 mM PBS, pH 6.0, containing 0.5% hexadecyl-
trimethylammonium bromide (HETAB) and 10 mM ethylenedia-
mine tetraacetic acid (EDTA). This homogenate was subjected to
one cycle of freezing/thawing and a brief period of sonication. A
sample of homogenate (0.5 mL) was added to a 0.5 mL reaction
volume containing 80 mM PBS, pH 5.4, 0.5% HETAB and 1.6 mM
3,30,5,50-tetramethylbenzidine. The mixture was incubated at 37 1C
for 5 min and the reaction started with the addition of 0.3 mMH2O2.
Each tube containing the complete reaction mixture was
incubated for exactly 3 min at 37 1C. The reaction was terminated
by the sequential addition of catalase (20 mg/mL) and 2 mL 0.2 M
sodium acetate, pH 3.0. The changes in absorbance at 655 nm were
measured with a spectrophotometer. One unit of MPO activity was
deﬁned as the amount of enzyme present that produced a change
in absorbance of 1.0 U/min at 37 1C in the ﬁnal reaction volume
containing the acetate. Results were quantiﬁed as U/mg tissue.
2.8. TNF-a levels
The TNF-a levels in distal colon tissues were measured by
quantitative enzyme immunoassay kits according to the manu-
facturer’s protocol (Quantikines M, R&D Systems). Colon samples
were weighed and homogenized at 4 1C, after thawing, in 0.3 mL
PBS (pH¼7.2), 1% bovine serum albumin (BSA) containing
0.01 mg/mL leupeptin, 0.01 mg/mL pepstatin, 0.01 mg/mL aproti-
nin, and 1 mM phenylmethylsulfonyl ﬂuoride (PMSF). Then they
were centrifuged at 15,300g for 10 min. The concentrations of
TNF-a were determined in duplicate and the values were
expressed as pg/mg tissue.
2.9. Isolation of cytoplasmic proteins and immunoblotting detection
Frozen colonic tissues were weighed and homogenized in ice-
cold hypotonic buffer (1.5 mM MgCl2, 10 mM KCl, 0.2 mM phe-
nylmethylsulfonyl ﬂuoride (PMSF), 1.0 mM dithiothreitol (DTT)
and 10 mM Hepes, pH 7.9). Homogenates were incubated for
10 min in ice and centrifuged (25,000g, 15 min, 4 1C). Cytoplasmic
proteins were collected from the supernatants. Protein concen-
tration of the homogenate was determined following Bradford
colorimetric method (Bradford, 1976). Aliquots of supernatants
containing equal amounts of protein (30–50 mg) were separated
on 10% acrylamide gel by sodium dodecyl sulfate–polyacrylamide
gel electrophoresis. In the next step, the proteins were electro-
phoretically transferred onto a nitrocellulose membrane and
incubated with speciﬁc primary antibodies (Santa Cruz Biotech-
nology, CA, USA) for COX-1 (M-20) at a dilution of 1:2000 and
COX-2 (M-19) at a dilution of 1:400. Each ﬁlter was washed three
times for 15 min and incubated with the secondary horseradish
peroxidase-linked anti-goat (for COX-1 and COX-2) (Santa Cruz
Biotechnology, CA, USA). To prove equal loading, the blots were
analyzed for b-actin expression using an anti-b-actin antibody
(Santa Cruz Biotechnology, CA, USA). Immunodetection was
performed using enhanced chemiluminescence light-detecting
kit (Amersham, Arlington Heights, IL, USA). Densitometry data
were studied following normalization to the control (housekeep-
ing gene). The signals were analyzed and quantiﬁed by a Scientiﬁc
Imaging System (KODAK 1D Image Analysis Software).2.10. Statistical analysis
All values in the ﬁgures and texts are expressed as arithmetic
means7standard error of the mean (SEM) or standard deviation
(SD). The data were evaluated with Graph Pad Prisms Version
2.01 software. The statistical signiﬁcance of differences for each
parameter among the groups was evaluated by one-way analysis
of variance (ANOVA) followed by Dunnett’s test. P values of
o0.05 were considered statistically signiﬁcant.3. Results
3.1. Protective effect of ONP fraction in acute TNBS-induced colitis in
rats
Rats treated with TNBS showed prostration, piloerection and
hypomotility. Macroscopic inspection of the cecum, colon and
rectum showed evidence of severe colonic mucosal damage, with
edema, deep ulcerations and hemorrhage. The animals were
severely anorexic, with a marked decrease in average food intake
compared to those of the vehicle-treated group variations
(Table 1). In addition, a signiﬁcant increase in the weight/length
of the rat colon (as an indicator of inﬂammation), presence of
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observed in TNBS-treated rats. On the contrary, ONP fraction
treatment (25 or 50 mg/kg) signiﬁcantly attenuated the extension
and severity of the colonic injury, reducing the macroscopic
damage score (po0.05) (Fig. 1), diminished the weight/length
of the rat colon and the presence of adhesions (Table 1).
3.2. Histological studies of the colon after ONP fraction treatment on
acute experimental TNBS model
The histological features of the colon from sham-treated rats were
typical of a normal structure (Figs. 2A and 3A) with normal intestinal
cytoarchitecture, epithelial cell layer accompanied by the presence ofFig. 2. ONP fraction reduces histological damage. Histological appearance of rat colonic
ethanol group; (D) TNBS groups; (E) ONP fraction 25 mg/kg group; and (F) ONP fractiogoblet cells in straight tubular gland and normal quantity number of
cells in lamina propria. On the other hand, the TNBS-treated group
showed severe signs of inﬂammation with transmural necrosis,
edema and diffuse inﬂammatory cells (polymorphonuclear leuko-
cytes, lymphocytes, and eosinophils) inﬁltration in the mucosa
(Fig. 2D). We assessed local ulceration of the colonic mucosa extend-
ing through the muscularis mucosae, as well as, desquamated areas or
loss of the epithelium (Fig. 2D). The architecture of the crypts was
distorted and the lamina propia was thickened in peripheral areas of
distorted crypts, especially in basal areas (Figs. 2D and 3D).
In order to examine the gel mucus layer, an integral structural-
protection of the intestine, the alcian blue staining technique was
used. In TNBS-treated group, some areas showed accumulation ofmucosa after haematoxylin and eosin stain: (A) sham group; (B) Tween group; (C)
n 50 mg/kg group. Original magniﬁcation 10x.
Fig. 3. ONP fraction reduces colonic inﬁltration in rat colon segments stained with giemsa. Histological appearance of rat colonic mucosa after giemsa stain: (A) sham
group; (B) Tween group; (C) ethanol group; (D) TNBS groups; (E) ONP fraction 25 mg/kg group; and (F) ONP fraction 50 mg/kg group. Original magniﬁcation 10x.
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less numerous. In fact, in some areas, the mucin layer of the
epithelium was missing (Fig. 4D). However, in TNBS-induced rats
treated with ONP fraction (25 or 50 mg/kg) some areas of the
epithelium remained intact and the mucin layer was clearly
visible (Fig. 4E and F).3.3. Assessment of leukocyte involvement
As shown in Table 2, a marked increase in MPO activity, an
inﬁltration indicator of the colon with polymorphonuclear leuko-
cytes also characterized the colitis induced by TNBS. This result
was consistent with the histological ﬁndings. Treatment of
Fig. 4. ONP fraction treatment prevents mucin layer loss. Histological appearance of rat colonic mucosa after alcian blue stain: (A) sham group; (B) Tween group; (C)
ethanol group; (D) TNBS groups; (E) ONP fraction 25 mg/kg group; and (F) ONP fraction 50 mg/kg group. Original magniﬁcation 10x.
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cantly (po0.01 and po0.05, respectively) reduced the degree of
polymorphonuclear neutrophil inﬁltration.3.4. TNF-a levels
Colonic injury by TNBS administration was also characterized
by an increase in the proinﬂammatory cytokine TNF-a level
(Table 2). In contrast, its levels were signiﬁcantly lower(po0.01 and po0.05) in the groups treated with ONP fraction
25 and 50 mg/kg, respectively.
3.5. Analysis for COX-1 and COX-2 protein expression
The levels of COX-1 and COX-2 expression were measured by
Western blotting of cytosolic extracts from colonic mucosa. The
levels of COX-1 protein remained unchanged in all groups,
indicating that COX-1 protein was constitutively expressed in
the colonic tissue and was not signiﬁcantly changed after TNBS
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hand, COX-2 protein was signiﬁcantly increased by the hapten
(po0.01), indicating that the inducible isoenzyme expression
could be induced at the early stage of colonic lesion caused by
TNBS. Nevertheless, oral administration of ONP fraction (50 mg/
kg) diminished the up-regulation of COX-2 expression (Fig. 5B).
3.6. Immunohistochemical observations
Speciﬁc immunosignals for COX-1 were obtained in the
epithelium surface, as well as in the upper half of the crypts from
normal colons. Mononuclear cells of the lamina propria and
regional lymphatic nodules as well as the cells of the muscularis
mucosae showed COX-1 speciﬁc immunosignals (Fig. 6B) in
comparison with negative control (Fig. 6A). In the basal part of
the crypts, COX-1 expression was restricted to individual cells,
which, according to morphological criteria are endocrine cells, a
specialized epithelial cell type of the lower crypt.
COX-2 speciﬁc immunolabelling was occasionally observed in
colonocytes of the normal surface epithelium of matched control
colon as shown in Fig. 7B. Compared with normal colon, sig-
niﬁcant changes in the cellular distribution of COX-1 and COX-2
were observed in animals treated with TNBS in those colonocytes
of the surface and the crypt epithelium, which were only weaklyTable 2
Myeloperoxidase activity (MPO, U/mg tissue) and tumor necrosis factor alpha
levels (TNF-a, pg/mg tissue) after ONP fraction (25 and 50 mg/kg p.o.) in rats with
acute colitis produced by TNBS intracolonic instillation (10 mg/kg). Data are
expressed as means7SEM. npo0.05, nnpo0.01 and nnnpo0.001, signiﬁcantly
different from Tween; þpo0.05, þþpo0.01 and þþþpo0.001, signiﬁcantly differ-
ent from TNBS.
Group MPO (U/mg tissue) TNF-a (pg/mg protein)
Tween 0.8270.18 0.0770.02
TNBS 1.7470.03nnn 0.6970.14nnn
TNBSþONP 25 mg/kg 0.9770.09þþ 0.1270.02þþ
TNBSþONP 50 mg/kg 1.1870.08þ 0.2670.04þ
Fig. 5. Analysis of COX-1 and COX-2 protein expressions by western bloting. (A) COX-1
(25 and 50 mg/kg p.o.), (B) COX-2 was down regulation in ONP fraction-treated groups
normalization to the control (b-actin house-keeping gene). The results are representati
mean7SEM ***po0.001 *po0.05 signiﬁcantly different from Tween group. þpo0.05stained by the COX-1 speciﬁc antiserum (Fig. 6D) whereas
prominent COX-2 expression was found in cells of the epithelium
surface and in the inﬂammatory inﬁltrate (Fig. 7D). COX-1
expression reﬂected no important differences in the cellular
localization and the degree of positive staining for COX-1 in colon
mucosa from ONP fraction-treated rats after treatment (Fig. 6E
and F). At this time, ONP fraction-treated rats showed a lower
level of expression of the inducible isoform in apical epithelial
cells of inﬂamed colon (Fig. 7E and F).4. Discussion
Animal models of intestinal inﬂammation are indispensable
for our understanding of the pathogenesis of CD and UC, the two
major forms of IBD in humans (Malik and Mannon, 2012). TNBS
model induces inﬂammation of the rat gut, characterized by
several clinical and histopathological features resembling those
of human IBD (te Velde et al., 2006).
Actually, the 5-aminosalicylic acid treatment is the ﬁrst choice
for IBD patients, however, these drugs are not entirely effective,
they are rather aimed at the remission of the disease and,
occasionally, the patients suffer with the worsening of the
symptoms (Ford et al., 2011). This aggravation is treated with
corticosteroids, but usually followed by heavy side effects and the
patients may become either dependent or resistant to the drugs
(Ford et al., 2011). In this context, novel treatment possibilities
are necessary. It has been widely shown that many plant-derived
compounds present signiﬁcant anti-inﬂammatory effects, espe-
cially when used for the treatment and/or control of chronic
inﬂammatory states such as IBD (Calixto et al., 2004).
The present study conﬁrmed, for the ﬁrst time, that treatment
with ONP fraction was able to reduce the severity and extent of
the acute colonic damage induced by TNBS. The decrease in the
extent and severity of colitis induced by this hapten was accom-
panied by a lower incidence of diarrhea and of loss of weight
of the animals and decrease in the incidence of adhesions.protein remained unchanged in all groups (Tween, TNBS and TNBSþONP) fraction
in comparison with TNBS control group. Densitometry data were studied following
ve of three experiments performed on different samples and data are expressed as
signiﬁcantly different from TNBS group.
Fig. 6. Immunohistochemical localization of COX-1 isoenzyme in sections of colon. (A) Sham group; (B) Tween group; (C) ethanol group; (D) TNBS groups; (E) ONP fraction
25 mg/kg group; and (F) ONP fraction 50 mg/kg group. Original magniﬁcations 10x.
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organs, which results from transmural inﬂammation, is a com-
mon feature of TNBS-induced colitis (Morris et al., 1989). The
reduction in the incidence of adhesions suggests a beneﬁcial
effect of ONP fraction on the extent of the inﬂammatory process
in this experimental model.
Our results also revealed that ONP fraction increased the
amount of mucus stained by alcian blue (acid glucoproteins such
as sialomucins) in colon mucosa. The mucus layer coating the
gastrointestinal tract is the front line of innate host defense,
largely because of the secretory products of intestinal goblet cells(Kim and Ho, 2010). Accumulating evidence indicates that com-
plex interactions are involved in the pathogenesis of IBD includ-
ing defective mucosal barrier function resulting from abnormal
synthesis and/or processing of mucins (Kim and Ho, 2010). Goblet
cells are reduced in number and size in UC. Recent studies in
murine models of colitis highlighted the importance of mucin at
maintaining the integrity of protective mucus barriers whose
breakdown can result in colitis (Kim and Ho, 2010). Our ﬁndings
demonstrate that ONP fraction increased the amount of alcian
blue positive cells (acid glucoproteins such as sialomucins) in the
colon mucosa. The increase in the intestinal mucus layer may be
Fig. 7. Immunohistochemical localization of COX-2 isoenzyme in sections of colon. (A) Sham group; (B) Tween group; (C) ethanol group; (D) TNBS groups; (E) ONP fraction
25 mg/kg group; and (F) ONP fraction 50 mg/kg group. Original magniﬁcations 10x.
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(Kim and Ho, 2010).
Chronic inﬂammation of the large intestine predominantly
comprises lymphocytes and plasma cells exacerbation, neutro-
phils migrate and degranulate substances like MPO (Masoodi
et al., 2011). MPO is an enzyme found in primary granules of
polymorphonuclear neutrophils and used as an index for the
severity of digestive inﬂammation (Masoodi et al., 2011). In fact, it
is well-known that this enzyme is increased in TNBS and DSS-
induced colitis (Lima de Albuquerque et al., 2010; Dutra et al.,
2011; De-Faria et al., 2012). On the contrary, ONP fraction
treatment led to reduced MPO activity in inﬂamed colon, pointing
out an inhibitory effect on granulocyte inﬁltration.The pathogenesis of IBD is originated from a combination of
inputs: a genetic predisposition, an environmental trigger, and an
abnormal immune response (Kavanaugh et al., 2011). Dysregula-
tion of either immunity or intestinal barrier function allows the
initiation of IBD resulting in chronic active inﬂammation with the
production of proinﬂammatory cytokines such as TNF-a (Lee and
Fedorak, 2010; Hai et al., 2011; Kavanaugh et al., 2011). TNF-a is a
pleiotropic cytokine that elicits a wide spectrum of physiologic
and pathogenic events such as proliferation, differentiation, cell
death, modulation of gene transcription, and inﬂammation (Qidwai
and Khan, 2011). Elevated levels of TNF-a have been observed in the
serum and feces of CD patients (Yin et al., 2011) and in the
experimental colitis (da Silva et al., 2010; De-Faria et al., 2012).
A.B.A. de Almeida et al. / Journal of Ethnopharmacology 146 (2013) 300–310 309In our experiment, the levels of TNF-a were signiﬁcantly increased
in the colon at 48 h after TNBS instillation. In contrast, the ONP
fraction-treated animals showed a signiﬁcant decline in the TNF-a
levels, corroborating with that demonstrated by Huang et al. (2010).
However, these authors assayed four-fold higher dose of Arctium
lappa in comparison with ours. Despite many inhibiting agents have
been tested and developed for the IBD treatment, the development
of TNF-a inhibitors markedly revolutionized the treatment of IBD.
These drugs have proven to effectively induce and maintain remis-
sion of the IBD (Wasan and Kane, 2011). Recent studies have
demonstrated that other sesquiterpenes are capable of modulating
the production of TNF-a (Fonseca et al., 2010; Ferrari et al., 2012;
Zhao et al., 2012).
In addition, TNF-a mediates important inﬂammatory signaling
pathways, including the COX-2 expression which plays a key role
in various inﬂammatory pathogenesis of the digestive tract,
including colitis (Agoff et al., 2000). COX is rate-limiting in the
synthesis of prostaglandins. COX-2 is the inducible isoform of
cyclooxygenase, the rate-limiting enzyme that catalyzes the
initial step of arachidonic acid metabolic transformation into
prostanoids. Studies have shown that inducible enzyme COX-2
is predominantly expressed at sites of inﬂammation. Increased
amounts of this protein have been found in experimental colitis
(Lima de Albuquerque et al., 2010; da Silva et al., 2010; De-Faria
et al., 2012). Conversely, COX-1 represents the constitutive iso-
form of COX (Rizzo, 2011; De-Faria et al., 2012). ONP fraction
reduced the COX-2 overexpression when compared with TNBS
group. Thus, we suggest that the anti-inﬂammatory activity
presented by ONP fraction could be mediated, in part, through
COX-2 down-regulation. Zwolinska-Wcislo et al. (2011) showed
that the treatment with COX-2 inhibitor decreased the area of
colonic lesions, MPO activity and expression of proinﬂammatory
markers such as TNF-a.5. Conclusion
In summary, our data reveal, for the ﬁrst time, that pre-
treatment with ONP fraction is able to reduce intestinal inﬂam-
mation in an acute TNBS-induced experimental model of colitis in
rats. This anti-inﬂamatory effect seems to be related to a decrease
in the neutrophil function, TNF-a production and COX-2 down-
regulation in the intestinal mucosa.Acknowledgments
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